LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial. (PubMed, JAMA) - Aug 30, 2026 - P4 | "However, no clinical benefit was detected during the first year of follow-up, arguing against clinically meaningful acute pleiotropic effects of PCSK9 inhibitors in addition to standard care. ClinicalTrials.gov Identifier: NCT04951856."
Clinical • Journal • Cardiovascular • Dyslipidemia • Myocardial Infarction
|
|
; Abdourahmane Diallo; Amel Chamam; Andrea Picchi; Àngel Cequier-Fillat; Benjamin Duband; Claire Bouleti; Emile Ferrari; Eric Vicaut; Etienne Fourrier; Flavien Vincent; Francois Mach; Géraud Souteyrand; Gilles Montalescot; Giovanni Esposito; Giuseppe Patti; Grégoire Rangé; Holger Thiele; J Wouter Jukema; Jean-Guillaume Dillinger; Johanne Silvain; Karine Brochard; Laure Batias-Moreau; Leonardo Bolognese; Marco Chioccioli; Mathieu Kerneis; Michel Zeitouni; Nassim Braik; Nassim Redjimi; Nicolas Vignolles; Niki Procopi; Paul Guedeney; Pierre Coste; Pierre Sabouret; Sinda Hannachi; Stanislaw Bartus; Stéphane Ederhy
|